Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
The company will participate in the ‘Macquarie Asia Conference 2025’ and hold Non-Deal Roadshow (NDR) IR sessions for major overseas institutional investors in Malaysia, Hong Kong, and Singapore.
📊 [Key Disclosure Contents & Summary of Major Figures]
- Date and Time: May 12, 2025 – May 20, 2025 (Specific time not specified)
- May 12 – May 13: Malaysia
- May 14 – May 16: Hong Kong
- May 19 – May 20: Singapore
- Location: Malaysia, Hong Kong, Singapore
- Target Audience: Major overseas institutional investors
- Purpose: Participation in ‘Macquarie Asia Conference 2025’ and overseas institutional investor NDR (Non-Deal Roadshow)
- Format: One-on-One and group meetings
- Sponsoring Institution: Macquarie Securities
- Summary of Main Topics:
- 2025 AI (HBM) market outlook
- Product roadmap for next-generation HBM4 production bonders (FLTCB, HB)
- Strategy to address HBM customer demand
- Decision Date: April 28, 2025
- IR Materials: Date and related URL not specified
- Other Material Details: Schedule subject to change based on company circumstances
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Execution of IR Sessions and Publication of Related Materials
This disclosure outlines the schedule for upcoming overseas NDR sessions and conference participation targeting major institutional investors. Tracking whether the roadshow proceeds according to the announced timeline and whether any associated IR presentation documents are released is important to confirm the follow-through on the announced plan. Related updates can be verified through subsequent IR-related disclosures or the official company website.
📢 Legal Disclaimer & Source Notice
Source: This content was structured and newly generated based on official filing data from the Financial Supervisory Service DART system.
Investment Risk Warning: This content is provided strictly for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial responsibilities rest entirely with the investor.
Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.
